Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06686420

Investigation of the Effects of a Bifidobacterial Strain on Bowel Movement in Healthy Adults

A Randomized, Double-blind, Placebo-controlled, Parallel Study, to Assess the Effect of Bifidobacterial Supplementation on Bowel Movements.

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
Morinaga Milk Industry Co., LTD · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to investigate whether a supplement containing the B. longum strain works to alleviate constipation in adults. The main questions it aims to answer are: Does a supplement containing the B. longum strain increase the number of spontaneous bowel movements per week, improve stool consistency, and enhance the quality of life? Participants will: Take a supplement containing the B. longum strain or a placebo every day for 8 weeks. Maintain an e-diary as per the instructions. Visit the clinic for screening assessments, baseline, and end of the intervention for stool sample submission.

Detailed description

Constipation significantly impacts the quality of life, and one of the main causes is the disruption of the gut microbiota. Probiotics have been reported to have a beneficial effect on the intestines, and Bifidobacteria, in particular, have shown functionality in relieving constipation.This randomized, placebo-controlled, clinical trial investigates the effect of Bifidobacterial supplementation intervention on bowel movement in healthy adults.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTB. longumOn the first day of the intervention period, participants will be instructed to consume two capsules of the live B. longum strain daily with a glass of water before breakfast for the next eight weeks.
DIETARY_SUPPLEMENTPlaceboOn the first day of the intervention period, participants will be instructed to consume two capsules, which are without any live bacteria, daily. They should take these before breakfast with a glass of water, for the following eight weeks.

Timeline

Start date
2024-05-01
Primary completion
2025-08-31
Completion
2026-12-31
First posted
2024-11-13
Last updated
2025-09-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06686420. Inclusion in this directory is not an endorsement.